Taming the AI Chaos in Drug Discovery
Key Points AI chaos is a success-driven challenge: Powerful, specialized AI tools are proliferating faster than labs can integrate them coherently. Fragmentation creates hidden costs:…
Artificial Intelligence
A Strong Dose of Digital for U.K. Pharma and Life Sciences
Earlier this year, the U.K. government announced £82.6 million ($102.2 million) in research funding for artificial intelligence (AI) companies engaged in developing solutions that accelerate…
From Support to Strategy: Will 2026 be the Year of the AI-augmented Medical Affairs Team?
Over the past several years, Medical Affairs has evolved from a largely supportive, reactive function into a primary strategic pillar. In 2026, proving the value…
Sword Intelligence Launches in the UK, Bringing Proven National-scale AI Care Operations set to Transform Healthcare in Greece
Following the announcement of a national collaboration with the Greek government, Sword Intelligence is bringing AI-led triage, care coordination and access operations to help the…
Are Pharma’s Data Transformation Efforts Targeting the Right Challenge?
For more than a decade life sciences organisations have spoken confidently about becoming data-driven; more recently about becoming AI-powered. Yet compared with other highly-regulated sectors,…
AI Ready-Healthcare Starts with Unified, Real-Time Data
This year, the healthcare industry will see AI shift from experimentation to execution. From predictive analytics that support earlier diagnosis to automation that reduces administrative…
Ethical use of AI in Social Care and the Importance of Human Overview
Adult social care in the UK is under unprecedented pressure – rising demand, workforce shortages and increasing complexity of needs are forcing the sector to…
2026: The Year We Choose What Matters in Health and Social Care AI
As we enter 2026, artificial intelligence has now moved beyond the hype cycle. The question is no longer whether AI will transform health and social…
Bridging the Diagnostics Gap – How to Finance Smarter Labs
The UK’s National Health Service (NHS) is increasingly struggling to meet its diagnostic targets. As of August 2025, over 1.6 million people were on waiting…
Scaling AVT in the NHS – Lessons from Early Adopters
NHS England’s recently published Medium-Term Planning Framework represents an important next step in the delivery of the 10-Year Plan. It takes the digital ambitions set…